Table 2

Overview of the recommendations provided in the guidelines

GuidelineCountryYearSymptom managementAntiviralsAntibioticsProphylaxis
China (MoH)54China2003RNSR*R
Dermatology Advisor47Global2017NSCNSR
DermNet48Global2014NSCNSR
ECDC56Europe2019NSNSNSR
eMedicine49Global2020NSCNSR
Ireland HPSC53Ireland2021NSCNSR
Medscape51Global2019RNSNSR
NCDC44Nigeria2019RNSR*R
PHE/UKHSA52England2019NSCNSR
Singapore FETP46Singapore2020NSNSNSR
Taiwan CDC45Taiwan2009NSNSNSR
UpToDate50Global2021RCNSR
US CDC55USA2018NSCNSR
WHO18Global2019NSCNSR
  • *If secondary complications; C, considered; NS, not specified; R, recommended.

  • CDC, Centers for Disease Control; ECDC, European Centre for Disease Control and Prevention; FETP, Singapore Field Epidemiology Training Programme; HPSC, Health Protection Surveillance Centre; MoH, Ministry of Health; NCDC, Nigeria Centre for Disease Control; PHE, Public Health England; UKHSA, UK Health Security Agency.